trending Market Intelligence /marketintelligence/en/news-insights/trending/yizrbbcasbhswieyxzodug2 content esgSubNav
In This List

VistaGen Therapeutics raises $2.3M from private placement

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


VistaGen Therapeutics raises $2.3M from private placement

VistaGen Therapeutics Inc. raised about $2.3 million from its private placement to individual investors.

The California-based company sold about 1.8 million units for $1.25 apiece.

Each unit consisted of one unregistered common share and a warrant to buy 1 unregistered common stock for $1.50 per share.

The company intends to use the proceeds for general working capital purposes.

VistaGen develops and commercializes medicines for depression and other central nervous system disorders.